Injeções de plasma rico em plaquetas para o tratamento da osteoartrite do joelho

Abstract Purpose: The aim of this consensus was to develop evidence‐ and expert‐ based patient‐focused recommendations on the appropriateness of intra‐ articular platelet‐rich plasma (PRP) injections in different clinical scenarios of patients with knee osteoarthritis (OA). Methods: The RAND/UCLA Appropriateness Method was used by the European Society of Sports Traumatology, Knee Surgery, and Arthroscopy (ESSKA), as well as the International Cartilage Regeneration and Joint Preservation Society (ICRS) to reach a consensus and produce recommendations for specific patient categories combining best available scientific evidence with the collective judgement of a panel of experts. Results: Scenarios were defined based on first treatment vs first injective treatment vs second injective treatment, age (80), tibiofemoral vs patellofemoral involvement, OA level (Kellgren–Lawrence/ KL 0–I/II–III/IV), and joint effusion (dry knee, minor‐mild or major effusion). Out of 216 scenarios, in 84 (38.9%) the indication was considered.